Oppenheimer (OPY) Competitors $67.77 +1.20 (+1.80%) As of 07/3/2025 03:30 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OPY vs. FBRC, MS, GS, SCHW, RJF, LPLA, SF, EVR, LAZ, and BGCShould you be buying Oppenheimer stock or one of its competitors? The main competitors of Oppenheimer include FBR & Co. (FBRC), Morgan Stanley (MS), The Goldman Sachs Group (GS), Charles Schwab (SCHW), Raymond James Financial (RJF), LPL Financial (LPLA), Stifel Financial (SF), Evercore (EVR), Lazard (LAZ), and BGC Group (BGC). These companies are all part of the "investment banking & brokerage" industry. Oppenheimer vs. Its Competitors FBR & Co. Morgan Stanley The Goldman Sachs Group Charles Schwab Raymond James Financial LPL Financial Stifel Financial Evercore Lazard BGC Group Oppenheimer (NYSE:OPY) and FBR & Co. (NASDAQ:FBRC) are both small-cap investment banking & brokerage companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation. Does the media favor OPY or FBRC? In the previous week, Oppenheimer had 5 more articles in the media than FBR & Co.. MarketBeat recorded 5 mentions for Oppenheimer and 0 mentions for FBR & Co.. Oppenheimer's average media sentiment score of 0.22 beat FBR & Co.'s score of 0.00 indicating that Oppenheimer is being referred to more favorably in the media. Company Overall Sentiment Oppenheimer Neutral FBR & Co. Neutral Which has higher earnings and valuation, OPY or FBRC? Oppenheimer has higher revenue and earnings than FBR & Co.. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOppenheimer$1.43B0.50$71.56M$6.7210.08FBR & Co.N/AN/AN/AN/AN/A Is OPY or FBRC more profitable? Oppenheimer has a net margin of 5.26% compared to FBR & Co.'s net margin of 0.00%. Oppenheimer's return on equity of 9.03% beat FBR & Co.'s return on equity.Company Net Margins Return on Equity Return on Assets Oppenheimer5.26% 9.03% 2.24% FBR & Co. N/A N/A N/A Do insiders & institutionals believe in OPY or FBRC? 32.3% of Oppenheimer shares are owned by institutional investors. Comparatively, 72.4% of FBR & Co. shares are owned by institutional investors. 34.3% of Oppenheimer shares are owned by insiders. Comparatively, 13.9% of FBR & Co. shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is OPY or FBRC a better dividend stock? Oppenheimer pays an annual dividend of $0.72 per share and has a dividend yield of 1.1%. FBR & Co. pays an annual dividend of $0.80 per share and has a dividend yield of 4.6%. Oppenheimer pays out 10.7% of its earnings in the form of a dividend. Oppenheimer has increased its dividend for 1 consecutive years. SummaryOppenheimer beats FBR & Co. on 8 of the 11 factors compared between the two stocks. Get Oppenheimer News Delivered to You Automatically Sign up to receive the latest news and ratings for OPY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OPY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPY vs. The Competition Export to ExcelMetricOppenheimerFIN IndustryFinance SectorNYSE ExchangeMarket Cap$713.28M$99.38B$12.11B$20.72BDividend Yield1.06%1.91%5.54%3.72%P/E Ratio10.0818.3920.0428.07Price / Sales0.505.3325.7138.44Price / Cash5.5122.9321.7022.53Price / Book0.823.632.284.58Net Income$71.56M$6.49B$1.00B$985.54M7 Day Performance2.52%3.36%2.25%2.79%1 Month Performance8.47%9.62%4.63%5.46%1 Year Performance37.21%47.84%538.61%15.06% Oppenheimer Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPYOppenheimer3.7296 of 5 stars$67.77+1.8%N/A+37.2%$713.28M$1.43B10.083,018FBRCFBR & Co.N/A$17.55flatN/AN/A$124.61MN/A0.00259MSMorgan Stanley4.7005 of 5 stars$141.08+0.3%$133.62-5.3%+44.2%$226.34B$107.29B16.5680,000Trending NewsBuyback AnnouncementGSThe Goldman Sachs Group4.8789 of 5 stars$708.51+2.6%$595.67-15.9%+55.0%$217.40B$126.85B16.4446,500Trending NewsAnalyst ForecastSCHWCharles Schwab4.607 of 5 stars$91.26+1.4%$89.40-2.0%+23.0%$165.82B$20.46B27.6532,100Positive NewsInsider TradeRJFRaymond James Financial4.6091 of 5 stars$153.35+0.1%$153.82+0.3%+32.4%$30.94B$14.92B14.7622,000Positive NewsEx-DividendAnalyst RevisionLPLALPL Financial4.3962 of 5 stars$374.97+2.7%$387.69+3.4%+37.5%$29.99B$12.39B25.956,900Positive NewsSFStifel Financial4.4843 of 5 stars$103.98+0.3%$105.50+1.5%+30.9%$10.68B$4.97B19.889,000News CoveragePositive NewsAnalyst DowngradeEVREvercore4.5339 of 5 stars$270.85+0.7%$250.57-7.5%+36.2%$10.60B$3.09B25.922,380LAZLazard4.42 of 5 stars$47.99+0.3%$46.33-3.5%+29.1%$5.41B$3.05B16.723,263Trending NewsAnalyst RevisionGap UpBGCBGC Group4.1976 of 5 stars$10.23+1.3%$14.50+41.7%+20.8%$4.99B$2.26B37.894,011 Related Companies and Tools Related Companies FBR & Co. Competitors Morgan Stanley Competitors The Goldman Sachs Group Competitors Charles Schwab Competitors Raymond James Financial Competitors LPL Financial Competitors Stifel Financial Competitors Evercore Competitors Lazard Competitors BGC Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OPY) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oppenheimer Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oppenheimer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
